Collectively, our findings reveal an actionable, epigenetic cause of cetuximab resistance and metastasis in advanced CRC involving a MIR100HG/hnRNPA2B1/TCF7L2 feedback loop. The gene discussed is HNRNPA2B1; the disease is colorectal carcinoma.